Login to Your Account

Financings Roundup

Wednesday, August 29, 2012
• Catalyst Pharmaceutical Partners Inc., of Coral Gables, Fla., agreed to sell 4 million shares of its common stock and warrants to purchase an aggregate of 1.2 million shares of common stock in a registered direct public offering.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription